Respira Therapeutics, Inc.
Clinical trials sponsored by Respira Therapeutics, Inc., explained in plain language.
-
Inhaled hope for PAH patients: new drug aims to ease the struggle to breathe
Symptom relief CompletedThis study tested a single inhaled dose of an experimental drug called RT234 in people with pulmonary arterial hypertension (PAH). The main goal was to see if the drug could safely improve how well participants could exercise and reduce their feeling of breathlessness during phys…
Phase: PHASE2 • Sponsor: Respira Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
First human test of new inhaled heart drug
Knowledge-focused CompletedThis was an early safety study to see how healthy people's bodies handled a new inhaled drug called RT234. Researchers tested single and repeated doses in 31 healthy volunteers to check for side effects and measure how the drug moved through the body. The drug is being developed …
Phase: PHASE1 • Sponsor: Respira Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC